3//SEC Filing
APLIN JOHN C 3
Accession 0001209191-11-007056
CIK 0001235007other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 1:04 PM ET
Size
11.3 KB
Accession
0001209191-11-007056
Insider Transaction Report
Form 3
ENDOCYTE INCECYT
APLIN JOHN C
Director
Holdings
- (indirect: By CID Seed Fund, L.P.)
Series C-1 Convertible Preferred Stock
→ Common Stock (123,190 underlying) - (indirect: By CID Equity Capital VIII, L.P.)
Series C-3 Convertible Preferred Stock
→ Common Stock (41,855 underlying) - (indirect: By CID Equity Capital VIII, L.P.)
Series C-1 Convertible Preferred Stock
→ Common Stock (246,380 underlying) - (indirect: By CID Seed Fund, L.P.)
Series C-3 Convertible Preferred Stock
→ Common Stock (20,705 underlying)
Footnotes (4)
- [F1]The reported securities are convertible at any time at the option of the reporting person, but automatically convert into shares of Common Stock on a 1-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
- [F2]Not applicable.
- [F3]John Aplin is a Class A member of CID Equity Partners VIII, LLC, which has the ultimate voting and investment power over shares held of record by CID Equity Capital VIII, L.P., and he may be deemed to have voting and investment power over shares held of record by CID Equity Capital VIII, L.P. Mr. Aplin disclaims beneficial ownership of the shares directly held by the entities affiliated with CID except to the extent of his individual pecuniary interest therein.
- [F4]John Aplin is a general partner of CID Seed Fund Partners I which has the ultimate voting and investment power over shares held of record by CID Seed Fund, L.P., and he may be deemed to have voting and investment power over shares held of record by CID Seed Fund, L.P. Mr. Aplin disclaims beneficial ownership of the shares directly held by the entities affiliated with CID except to the extent of his individual pecuniary interest therein.
Issuer
ENDOCYTE INC
CIK 0001235007
Entity typeother
IncorporatedIN
Related Parties
1- filerCIK 0001033188
Filing Metadata
- Form type
- 3
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 1:04 PM ET
- Size
- 11.3 KB